The Magazine of Corporate Responsibility

Corporate Political Spending rss

Drug Industry Lobbyists and Campaign Cash Stymie Bid to Restrain Medicare Prescription Costs(0)

October 18, 2016

When Congress approved the landmark Medicare Part D program in 2003 to help seniors buy prescription drugs, it slapped on an unusual restriction: The federal government was barred from negotiating cheaper prices for those medicines. The ban on government price bargaining, justified by supporters on free market grounds, has been derided by critics as a giant gift to the drug industry.

Full Story»

Corporate Speech and the First Amendment: History, Data and Implications

A 2015 working paper from Harvard Law School, “Corporate Speech and the First Amendment: History, Data and Implications,” indicates that Citizens United, while certainly important, is only the latest in a series of cases that have expanded corporate use of the First Amendment. In his research, the author, John C. Coates IV, performed an analysis of nearly 13,000 Supreme Court decisions from 1946 to December 2014.

Inside the New York Fed: Secret Recordings and a Culture Clash

A special examiner hired – and fired – by the Federal Reserve Bank of New York recorded about 46 hours of meetings and conversations with her colleagues. Many of these events document key moments leading to her firing. But they also offer an intimate study of the New York Fed’s culture at a pivotal moment in its effort to become a more forceful financial supervisor.

House Finance Chair Goes on Ski Vacation with Wall Street

In January, Rep. Jeb Hensarling, R-Texas, ascended to the powerful chairmanship of the House Financial Services Committee. Six weeks later, campaign finance filings and interviews show, Hensarling was joined by representatives of the banking industry for a ski vacation fundraiser at a posh Park City, Utah, resort.


More in this category